ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FD02 | BioTech | Pertuzumab - 420mg/14ml | 7629/388 | 187053/13 | PERJETA 420MG | 420mg/14ml | 1 | Injectable concentrate for solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 03/10/20 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FD02 | BioTech | Pertuzumab - 420mg/14ml | 7629 | 187053/13 | PERJETA 420MG | 420mg/14ml | 1 | Injectable concentrate for solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 220,054,714 L.L | 2.44 | E2 | F. Hoffmann La Roche Ltd | Switzerland | 03/10/20 | |
L01FD02 | BioTech | Pertuzumab - 420mg/14ml | 12278 | 138325/1 | PERTUVIA | 420mg/14ml | 1x14ml | Injectable concentrate for solution | Infusion | Levant Pulse SARL | Manufactured Qilu Pharmaceutical Co Ltd Packed by Alfa Laboratoires S.A.L. | Lebanon | 147,592,404 L.L | 2.44 | E2 | Alfa Laboratoires S.A.L. | Lebanon | 03/10/20 |